Skip to main content

Laryngeal Edema

  • Chapter
  • First Online:
Pediatric Immunology
  • 55 Accesses

Abstract

Hereditary angioedema (HAE) is characterized by recurrent episodes of angioedema, without urticaria or pruritus

HAE often affects the skin and mucosal tissues of the upper respiratory and gastrointestinal tracts

Laryngeal attack is a common life-threatening complication and may cause fatal asphyxiation

Worldwide incidence of HAE estimated from 1:10,000 to 1:50,000

HAE has an autosomal dominant inheritance, while up to 20–25% patients may have new spontaneous mutations

Decrease activity or absence of C1-INH results leads to excessive bradykinin production during angioedema attacks

C4 and C1-INH level and function, are the key laboratory values in the diagnosis of hereditary angioedema

Patients with hereditary angioedema have poor response to treatment with antihistamines and steroids

First-line therapies for HAE are human plasma-derived C1 inhibitor concentrate or recombinant human C1 inhibitor, which are available only in the European Union, or Icatibant, a bradykinin B2 receptor antagonist

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bowen T. Hereditary angioedema: beyond international consensus - circa December 2010 - The Canadian Society of Allergy and Clinical Immunology Dr. David McCourtie Lecture. Allergy Asthma Clin Immunol. 2011;7(1):1.

    Article  Google Scholar 

  2. Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, Aygoeren-Pürsün E, Craig T, Binkley K, Hebert J, Ritchie B, Bouillet L, Betschel S, Cogar D, Dean J, Devaraj R, Hamed A, Kamra P, Keith PK, Lacuesta G, Leith E, Lyons H, Mace S, Mako B, Neurath D, Poon MC, Rivard GE, Schellenberg R, Rowan D, Rowe A, Stark D, Sur S, Tsai E, Warrington R, Waserman S, Ameratunga R, Bernstein J, Björkander J, Brosz K, Brosz J, Bygum A, Caballero T, Frank M, Fust G, Harmat G, Kanani A, Kreuz W, Levi M, Li H, Martinez-Saguer I, Moldovan D, Nagy I, Nielsen EW, Nordenfelt P, Reshef A, Rusicke E, Smith-Foltz S, Späth P, Varga L, Xiang ZY. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010;6(1):24.

    Article  Google Scholar 

  3. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):267–74.

    Article  Google Scholar 

  4. Craig T, Aygoren-Pursun E, Bork K, Bowen T, Boysen H, Farkas H, Grumach A, Katelaris CH, Lockey R, Longhurst H, Lumry W, Magerl M, Martinez-Saguer I, Ritchie B, Nast A, Pawankar R, Zuraw B, Maurer MWAO. Guideline for the management of hereditary angioedema. World Allergy Organ J. 2012;5(12):182–99.

    Article  Google Scholar 

  5. Farkas H, Varga L, Szeplaki G, Visy B, Harmat G, Bowen T. Management of hereditary angioedema in pediatric patients. Pediatrics. 2007;120(3):e713–22.

    Article  Google Scholar 

  6. Wahn V, Aberer W, Eberl W, Fasshauer M, Kuhne T, Kurnik K, Magerl M, Meyer-Olson D, Martinez-Saguer I, Spath P, Staubach-Renz P, Kreuz W. Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies. Eur J Pediatr. 2012;171(9):1339–48.

    Article  CAS  Google Scholar 

  7. Ebo DG, Verweij MM, De Knop KJ, Hagendorens MM, Bridts CH, De Clerck LS, Stevens WJ. Hereditary angioedema in childhood: an approach to management. Paediatr Drugs. 2010;12(4):257–68.

    Article  Google Scholar 

  8. Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med. 2001;161(5):714–8.

    Article  CAS  Google Scholar 

  9. Farkas H, Jakab L, Temesszentandrasi G, Visy B, Harmat G, Fust G, Szeplaki G, Fekete B, Karadi I, Varga L. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol. 2007;120(4):941–7.

    Article  CAS  Google Scholar 

  10. Grigoriadou S, Longhurst HJ. Clinical immunology review series: an approach to the patient with angio-oedema. Clin Exp Immunol. 2009;155(3):367–77.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Volokha, A. (2019). Laryngeal Edema. In: Rezaei, N. (eds) Pediatric Immunology. Springer, Cham. https://doi.org/10.1007/978-3-030-21262-9_120

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21262-9_120

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21261-2

  • Online ISBN: 978-3-030-21262-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics